Hepamelzolorax (L-Aspartic Acid-L-Ornithine)
L-Ornithine-L-Aspartate 3g
Solution · OTC medication
Hanwha Pharmaceutical Co., Ltd.
MFDS item code 201604820 · Notified 2016.08.08
This product's status changed to Approval withdrawn on 2026.02.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Adjunctive treatment for severe liver disease detoxification
This medication is used as an adjunct treatment to help restore liver function and assist in detoxification in cases of severe liver disease, particularly in conditions such as cirrhosis. It promotes the elimination of toxins from the body, helping to alleviate symptoms. This treatment contributes to reducing the burden on the liver and improving the overall condition of the liver. Therefore, it plays an important role in the treatment process for patients with severe liver disease.
As L-Aspartic Acid-L-Ornithine, take 6 g per dose, twice a day. Dissolve in a large amount of water and take after meals (for powder form). Take after meals (for liquid form).
This medication should not be taken by individuals with very poor kidney function, especially those with a creatinine level of 3 mg/100 mL or higher in blood tests. Individuals allergic to acetylsalicylic acid should consult with a doctor, dentist, or pharmacist before taking this medication. This is especially important for those who have had allergic symptoms such as asthma. If any unusual symptoms occur while taking this medication, you should immediately stop taking it and consult a specialist. Additionally, if symptoms do not improve after taking it for about 2 weeks, stop taking it and consult a doctor or pharmacist. It is important to adhere to the prescribed dosage and dosing schedule, and not to change the dosage on your own. This medication should be stored out of reach of children in a safe place, away from direct sunlight, and in a cool place with low humidity. Moreover, transferring the medication from its original container to another container may compromise its quality or increase the risk of misuse, so it must be stored in its original container with the cap tightly closed.
Since adverse reactions may occur when taking this medication, you should immediately stop taking it and consult a specialist if any adverse reactions occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to keep it at a cool room temperature between 1 degree and 30 degrees Celsius.
Orange-colored liquid with an orange scent
30 mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Ornithine-L-Aspartate 3g
Solution · OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Prescription medication
Hanwha Pharm Co., Ltd.
L-Ornithine-L-Aspartate 3g
OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Daewon Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.